Impact of administration route and gene polymorphisms on the serum concentration of voriconazole among Chinese patients with hematologic malignancies
AimsVoriconazole (VRC) is recommended as the first-line treatment for invasive fungal diseases (IFDs). Therapeutic drug monitoring (TDM)-based dose adjustments can be performed to implement the individualized use of VRC in clinical practice. Numerous studies have shown significant interindividual di...
Saved in:
| Main Authors: | Zhiyao Chen, Menghua Zhang, Lin Wang, Yuzhu Cheng, Liyan Miao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1445583/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Population Pharmacokinetics Study of Venetoclax Concomitant with Voriconazole in Patients with Hematologic Malignancies
by: Yang J, et al.
Published: (2025-05-01) -
Plasma concentration of voriconazole under concomitant use of nirmatrelvir/ritonavir in patients with COVID-19: a multicenter retrospective study
by: Hao Shi, et al.
Published: (2025-08-01) -
CYP2C19 variability and clinical outcomes of clopidogrel, proton pump inhibitors, and voriconazole in Southeast Asia: a systematic review and meta-analysis
by: Harri Hardi, et al.
Published: (2025-06-01) -
CYP2C19‐Guided Voriconazole Therapy: A Precision Medicine Approach to Mitigate Adverse Effects in Japanese Patients
by: Yoshiki Katada, et al.
Published: (2025-08-01) -
Vancomycin therapeutic drug monitoring: focus on patients with hematological malignancies
by: Yifan Luo, et al.
Published: (2025-12-01)